Sunday, June 10, 2012

How to Make Prescription Drugs Affordable

No surprise this excellent idea was turned into legislation by Senator Bernie Sanders, who does this valuable duty about once a week.

Dean Baker in The Guardian:

Drugs are cheap. There are few drugs that would sell for more than $5-$10 a prescription in a free market. However, many drugs in the United States sell for hundreds of dollars per prescription and, sometimes, several thousand dollars per prescription. There is a simple reason for this fact: government-granted patent monopolies.

The government gives patent monopolies to provide an incentive for drug companies to carry through research. This is an incredibly backward and inefficient way to pay for research. It leaves us paying huge amounts of money for cheap drugs. It also often leads to bad medicine.

We can do better – and Senator Bernie Sanders has proposed a way. He has introduced a bill to create a prize fund that would buy up patents, so that drugs could then be sold at a free market price. Sanders's bill would appropriate 0.55% of GDP (about $80bn a year, with the economy's current size) for buying up patents, which would then be placed in the public domain so that any manufacturer could use them at no cost.

This money would come from a tax on public and private insurers. The savings from lower-cost drugs would immediately repay more than 100% of the tax.

SNIP

The Sanders prize fund bill would go far towards eliminating the problems that pervade the drug industry. First, it would end the nonsense around getting insurers or the government to pay for drugs. If drugs cost $5-$10 per prescription, there would be no big issues about who pays for drugs. This would eliminate the need for the paperwork and the bureaucracy that the insurance industry has created to contain its drug payments.

We would also end the phony moral dilemmas we create for ourselves with drug patents. Should Medicare pay $100,000 a year for a drug to treat a rare cancer in an otherwise healthy 80 year old? This dilemma becomes a quick no-brainer when the drug is available for $200 a year in the free market with no patent protection.

The Sanders prize fund could also put an end to many of the deceptive marketing practices that the industry now employs to push their drugs, overstating the benefits of their drugs and concealing potentially harmful side-effects. It is rare that a month goes by when there is not a scandal along these lines. If the drug companies no longer stood to gain billions in profits from such deceptive marketing, they wouldn't do it. It would also likely reduce much of the waste in the current research process. Drug companies often spend large sums developing copycat drugs that are of little medical value, but can allow them to get a portion of a competitor's patent rents.

SNIP

The Centres for Medicare and Medicaid Research project that we will spend almost $4tn on prescription drugs over the next decade. This is almost $10,000 for every man, woman and child in the country. It's long past time that we did some serious thinking to ensure that we are getting better value for this money. The Sanders prize fund bill is an important step in this direction.

The only downside of this plan is that it does not put trillions of taxpayer dollars into the pockets of the already obscenely wealthy parasite class.

So of course repugs will reject it.

No comments: